Sinista Pharmaceuticals Private Limited
About Sinista Pharmaceuticals Private Limited
Data last updated:
Sinista Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 07 March 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2017PTC314060. Its GSTIN is 10AAYCS2809L1ZZ (Bihar).
The company has an authorised share capital of ₹6 Lakh and a paid-up capital of ₹6 Lakh. It is led by directors Srishty Kumari and Jyotish Kumar.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.In Kh.No. – 1788/438 G.Floor Asola Fatehpur Beri, New Delhi, Delhi, India – 110074.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.23 Cr, a growth of 31% compared to the previous year. For the same year it recorded a net profit of ₹7.26 Lakh (net margin 5.9%) and EBITDA of ₹8.85 Lakh (EBITDA margin 7.2%). Revenue has grown at a compounded annual rate (CAGR) of 41% over three years and 54% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Sinista Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressH.In Kh.No. – 1788/438 G.Floor Asola Fatehpur Beri, New Delhi, Delhi, India – 110074
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Sinista Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sinista Pharmaceuticals is trade. In detail, this covers wholesale trading and retail trading. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | |
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Sinista Pharmaceuticals Private Limited, buy the company report.
Financials of Sinista Pharmaceuticals Private Limited
FY 2025 filings availableSinista Pharmaceuticals Private Limited reported revenue of ₹1.23 Cr (up 31% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 54% over five years, including 31% growth in the latest year. EBITDA rose 599% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹8.85 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.26 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.2% | ||||
| Net Profit Margin | 5.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sinista Pharmaceuticals Private Limited, buy the company report.
Board of directors of Sinista Pharmaceuticals Private Limited
Sinista Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Srishty Kumari | Director | 06 Aug 2019 | 7 Years 2 Months | Current |
| Jyotish Kumar | Director | 07 Mar 2017 | 9 Years 7 Months | Current |
Peer comparison
Sinista Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dermont Pharmaceuticals Private Limited | ₹1.24 Cr (FY 2025) | 14.0% | Jaipur, Rajasthan, India | |||
| Elixolife Pharmaceuticals Private Limited | ₹1.24 Cr (FY 2025) | -22.0% | Pilkhuwa, Uttar Pradesh, India | |||
| Sinista Pharmaceuticals Private Limitedthis company | ₹1.23 Cr (FY 2025) | ₹7.26 Lakh | 5.9% | 31.0% | New Delhi, Delhi, India | |
| Unisarsh Pharmaceuticals Private Limited | ₹1.23 Cr (FY 2025) | 5.0% | Patna, Bihar, India | |||
| Oculus Pharmaceuticals Private Limited | ₹1.22 Cr (FY 2025) | -10.0% | Allahabad, Uttar Pradesh, India |
To see the full peer comparison of Sinista Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sinista Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sinista Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sinista Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAYCS2809L1ZZ | Bihar | Active | 19 Feb 2019 |
To see the full GST registrations and return filing status of Sinista Pharmaceuticals Private Limited, buy the company report.
Recent activity
Sinista Pharmaceuticals Private Limited has 4 board changes on record since 2017: 2 appointments and 2 cessations. The latest: Rashmi Rekha ceased to be Director on 07 Aug 2019.
Frequently asked questions
Sinista Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in specialty, within the trading industry. It was incorporated on 07 March 2017 (9+ years old) and is registered under CIN U51909DL2017PTC314060.
Sinista Pharmaceuticals has 2 current directors:
- Srishty Kumari - Director
- Jyotish Kumar - Director
The latest financial statements of Sinista Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Sinista Pharmaceuticals is 10AAYCS2809L1ZZ, registered in Bihar.
The CIN (Corporate Identification Number) of Sinista Pharmaceuticals is U51909DL2017PTC314060. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sinista Pharmaceuticals was incorporated on 07 March 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Sinista Pharmaceuticals by revenue are Dermont Pharmaceuticals Private Limited, Elixolife Pharmaceuticals Private Limited, Unisarsh Pharmaceuticals Private Limited, Oculus Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Rashmi Rekha ceased to be Director on 07 Aug 2019. Srishty Kumari was appointed as Director on 06 Aug 2019. Avinash ceased to be Director on 22 Mar 2018. Sinista Pharmaceuticals has 4 board changes on record in total.
The registered office of Sinista Pharmaceuticals is at H.In Kh.No. – 1788438 G.Floor Asola Fatehpur Beri, New Delhi, Delhi, India – 110074.
Sinista Pharmaceuticals operates in the trading industry, in the specialty segment.
The compliance status of Sinista Pharmaceuticals is compliant as of 07 August 2026. The company is actively filing with the Registrar of Companies.